⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMY News
Bristol-Myers Squibb Co.
Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection
businesswire.com
BMY
Bristol Myers Squibb’s Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimer’s Disease
businesswire.com
BMY
Bristol Myers Squibb Announces Phase 3 EXCALIBER-RRMM Study Evaluating Iberdomide in Combination with Standard Therapies Demonstrated a Significant Improvement in Minimal Residual Disease Negativity Rates in Relapsed or Refractory Multiple Myeloma
businesswire.com
BMY
Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises
prnewswire.com
TEM
CRSP
BNTX
BMY
TEM
CRSP
BNTX
BMY
Advancing Cancer Research Brings New Hope for Patients Worldwide
prnewswire.com
IOVA
MRK
AZN
BMY
Bristol Myers Squibb Announces Dividend
businesswire.com
BMY